Free-floating anxiety
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Irrational thoughts
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1
|
1
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Adolescent - emotional problem
|
disease |
|
Mental or Behavioral Dysfunction
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Episodic tension-type headache
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
1
|
1
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Schizophrenia Spectrum and Other Psychotic Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Chronic Daily Headache
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Gender disorders
|
group |
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
PARKINSON DISEASE 10
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Stimulant dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Physical Anhedonia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Verbal hallucinations
|
phenotype |
|
Sign or Symptom
|
2
|
1
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
SCHIZOPHRENIA, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
2
|
3
|
0.100 |
None |
|
0 |
1
|
|
|
Musculoskeletal Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases
|
Finding
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Cardiovascular symptoms
|
phenotype |
|
Sign or Symptom
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Drug-induced paranoid state
|
disease |
|
Mental or Behavioral Dysfunction
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
headache severe
|
phenotype |
|
Sign or Symptom
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Chronic Headache
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Chronic tension-type headache
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
4
|
1
|
0.010 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Primary spermatogenic failure
|
disease |
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Polysubstance abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Chronic Cancer Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
4
|
1
|
0.010 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Kleine-Levin Syndrome
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Algophobia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
6
|
4
|
0.020 |
None |
1.000 |
2 |
2
|
2018 |
2018 |
Dissociative disorder
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
6
|
1
|
0.010 |
None |
< 0.001 |
1 |
1
|
2013 |
2013 |